Alverno Laboratories, one of the largest integrated laboratory networks in the United States, has added two key Chicago hospital laboratories, along with several suburban AMITA Health hospital laboratories.

Hammond, Indiana-based Alverno Laboratories has added Mount Sinai Hospital, 1500 S. Fairfield Ave., and Holy Cross Hospital, 2701 W. 68th St., plus eight suburban AMITA hospitals to its integrated laboratory system. It increases the number of hospitals in Alverno’s network to 36, doubling the 18 Alverno partnered with in 2005.  “It expands our footprint and Alverno’s reach into new communities and enables these hospitals to have access to our world-class technology not available in the typical hospital laboratory,” said Alverno’s CEO Sam Terese.

He went on to say, “Our hospitals will be able to optimize their onsite time-dependent test menu to provide excellent care to patients, while taking advantage of the lowered cost of sending non-time dependent testing to the central laboratory.”                                                             

The AMITA Health hospitals added to the Alverno system are: AMITA Health Adventist Medical Center Bolingbrook; AMITA Health Adventist Medical Center Glen Oaks; AMITA Health Adventist Medical Center Hinsdale; AMITA Health Adventist Medical Center La Grange; AMITA Health Alexian Brothers Medical Center Elk Grove Village and AMITA Health St. Alexius Medical Center Hoffman Estates.

“The additional hospital volumes will require Alverno to add 20 associates to the central lab and will increase the total number of associates from 1,700 to around 2,100”, Terese said. Terese added that Alverno’s next goal is to investigate expansion into neighboring states and addition hospitals. “We have a workforce that is really excited about being part of our expanding and growing organization,” Terese said. “We look at our expansion as having the ability to improve outcomes for more patients and help save more lives. Alverno is revered for what it does and what it stands for, and that brings us to a visionary perspective of growth.”

Alverno, which is celebrating its 20th anniversary this year, is one of the largest integrated laboratory networks in the United States. It owns and operates hospital laboratories in Illinois and Indiana, and features a central laboratory performing both clinical and anatomic pathology. Alverno’s innovative, state-of-the-art laboratory offers cost effective testing and personalized customer service, with advanced technology and testing in Precision Medicine/Next-Gen Sequencing, toxicology and other speciality testing. Alverno’s on-site pathologists are part of the pathology practice of Pathology Consultants, Inc.

Terese has been with the company since 2005, first as Vice President, then as Chief Operating Officer, and, since Sept. 8, 2011, as its President and CEO.

In the last decade under Terese’s leadership, Alverno’s revenue has averaged 20 percent yearly growth, and this year alone the company has made numerous major announcements, including Alverno becoming the first U.S.-based network to launch groundbreaking digital pathology services from Royal Philips that will allow pathologists to assess and diagnose all clinical histology cases digitally, instead of using a microscope.

Mount Sinai Hospital, a 319-licensed acute care bed hospital, provides a wide array of quality medical, surgical, behavioral health, therapeutic and diagnostic services.

Holy Cross Hospital, a 264-licensed bed community hospital, provides inpatient and outpatient care for a range of services that include medical, surgical, intensive care, emergency, labor and delivery, behavioral health, and primary care services, as well as hospice and palliative care services operated by Seasons Hospice.

AMITA Health is rooted in faith-based health systems that have served Chicago’s northwest, west and southwestern suburbs for more than 100 years.

“These hospitals value our model, and this expansion news is kind of a celebration for us doing things right,” Terese said. “We all work tremendously hard, but we’re having fun doing it.”

For more information on Alverno Laboratories, visit https://alvernolabs.com/